Page last updated: 2024-12-08

6,6'-dibromoindigo

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6,6'-dibromoindigo: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID177057
CHEBI ID80914
SCHEMBL ID11920847
MeSH IDM0552126

Synonyms (32)

Synonym
19201-53-7
6,6'-dibromoindigotin
tyrian purple
C17084
6,6'-dibromoindigo
AKOS004906821
indigoin, 6,6'-dibromo-
c.i. 75800
c.i. natural violet 1
SCHEMBL11920847
3h-indol-3-one,6-bromo-2-(6-bromo-1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,2-dihydro-
2O3DDL8TAF ,
6,6-dibromoindigo
6,6-dibromoindigo [mi]
3h-indol-3-one, 6-bromo-2-(6-bromo-1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,2-dihydro-, (2e)-
CHEBI:80914
3h-indol-3-one, 6-bromo-2-(6-bromo-1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,2-dihydro-
unii-2o3ddl8taf
1277170-99-6
AKOS030241688
6,6'-dibromindigo
mfcd01081325
pourpre
BCP23747
(2e)-6-bromo-2-(6-bromo-3-oxo-1,3-dihydro-2h-indol-2-ylidene)-1,2-dihydro-3h-indol-3-one
Q5180360
6-bromo-2-(6-bromo-3-hydroxy-1h-indol-2-yl)indol-3-one
DTXSID801314818
(e)-6,6'-dibromo-[2,2'-biindolinylidene]-3,3'-dione
(2e)-6-bromo-2-(6-bromo-1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,2-dihydro-3h-indol-3-one
DTXSID301124185
6,6'-dibromo-[2,2'-biindolinylidene]-3,3'-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's15 (83.33)24.3611
2020's3 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.55 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]